Anti-invasive and anti-migratory effects of ononin on human osteosarcoma cells by limiting the mmp2/9 and egfr-erk1/2 pathway

HIGHLIGHTS

• who: Guowei Gong and collaborators from the Department of Bioengineering, Zunyi Medical University, Zhuhai Campus, Zhuhai, China have published the paper: Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway, in the Journal: Cancers 2023, 758 of /2023/
• what: The authors aimed to investigate the efficacy of ononin on osteosarcoma cell migration invasion and the underlying mechanisms.
• how: The results were compared with the standard chemotherapeutic drug doxorubicin (DOX) as a positive control. For consistency the authors used the MG . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.